201 related articles for article (PubMed ID: 38019177)
1. Generalized pustular psoriasis: practical recommendations for Spanish primary care and emergency physicians.
Rivera-Diaz R; Epelde F; Heras-Hitos JA; Martínez Virto AM; Dávalos Marin AJ; Senán Sanz MR; Carrascosa JM
Postgrad Med; 2023 Nov; 135(8):766-774. PubMed ID: 38019177
[TBL] [Abstract][Full Text] [Related]
2. A brief guide to pustular psoriasis for primary care providers.
Crowley JJ; Pariser DM; Yamauchi PS
Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
[TBL] [Abstract][Full Text] [Related]
3. Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular Psoriasis.
Morita A; Choon SE; Bachelez H; Anadkat MJ; Marrakchi S; Zheng M; Tsai TF; Turki H; Hua H; Rajeswari S; Thoma C; Burden AD
Dermatol Ther (Heidelb); 2023 Jan; 13(1):347-359. PubMed ID: 36333618
[TBL] [Abstract][Full Text] [Related]
4. Clinical Course and Characteristics of Generalized Pustular Psoriasis.
Choon SE; Navarini AA; Pinter A
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):21-29. PubMed ID: 35061227
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of hospitalizations and emergency department visits due to generalized pustular psoriasis in the United States.
Hanna ML; Singer D; Bender SD; Valdecantos WC; Wu JJ
Curr Med Res Opin; 2021 Oct; 37(10):1697-1703. PubMed ID: 34289766
[TBL] [Abstract][Full Text] [Related]
6. Generalized pustular psoriasis is a disease distinct from psoriasis vulgaris: evidence and expert opinion.
Bachelez H; Barker J; Burden AD; Navarini AA; Krueger JG
Expert Rev Clin Immunol; 2022 Oct; 18(10):1033-1047. PubMed ID: 36062811
[TBL] [Abstract][Full Text] [Related]
7. Unmet Medical Needs in the Treatment and Management of Generalized Pustular Psoriasis Flares: Evidence from a Survey of Corrona Registry Dermatologists.
Strober B; Kotowsky N; Medeiros R; Mackey RH; Harrold LR; Valdecantos WC; Flack M; Golembesky AK; Lebwohl M
Dermatol Ther (Heidelb); 2021 Apr; 11(2):529-541. PubMed ID: 33638115
[TBL] [Abstract][Full Text] [Related]
8. Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line.
Strober B; Leman J; Mockenhaupt M; Nakano de Melo J; Nassar A; Prajapati VH; Romanelli P; Seneschal J; Tsianakas A; Wei LY; Yasuda M; Yu N; Hernandez Daly AC; Okubo Y
Dermatol Ther (Heidelb); 2022 Feb; 12(2):381-393. PubMed ID: 34904208
[TBL] [Abstract][Full Text] [Related]
9. Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment.
Rivera-Díaz R; Daudén E; Carrascosa JM; Cueva P; Puig L
Dermatol Ther (Heidelb); 2023 Mar; 13(3):673-688. PubMed ID: 36635445
[TBL] [Abstract][Full Text] [Related]
10. Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health Records.
Zema CL; Valdecantos WC; Weiss J; Krebs B; Menter AM
JAMA Dermatol; 2022 Oct; 158(10):1142-1148. PubMed ID: 35947363
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of Generalized Pustular Psoriasis.
Fujita H; Gooderham M; Romiti R
Am J Clin Dermatol; 2022 Jan; 23(Suppl 1):31-38. PubMed ID: 35061226
[TBL] [Abstract][Full Text] [Related]
12. A narrative review of the socioeconomic burden associated with generalised pustular psoriasis.
Zimmermann TM; Hofmann P; Chiu GR
Exp Dermatol; 2023 Aug; 32(8):1219-1226. PubMed ID: 37309747
[TBL] [Abstract][Full Text] [Related]
13. The role of the interleukin-36 axis in generalized pustular psoriasis: a review of the mechanism of action of spesolimab.
Hawkes JE; Visvanathan S; Krueger JG
Front Immunol; 2023; 14():1292941. PubMed ID: 38077370
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis Flares.
Choon SE; Lebwohl MG; Turki H; Zheng M; Burden AD; Li L; Quaresma M; Thoma C; Bachelez H
Dermatology; 2023; 239(3):345-354. PubMed ID: 36796336
[TBL] [Abstract][Full Text] [Related]
15. Exploring the Clinical Presentation, Course, and Burden of Disease in Generalized Pustular Psoriasis [Podcast].
Merola JF; Amin AZ
Clin Cosmet Investig Dermatol; 2024; 17():539-545. PubMed ID: 38482176
[TBL] [Abstract][Full Text] [Related]
16. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
Menter A; Van Voorhees AS; Hsu S
Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
[TBL] [Abstract][Full Text] [Related]
17. Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.
Choon SE; Lebwohl MG; Marrakchi S; Burden AD; Tsai TF; Morita A; Navarini AA; Zheng M; Xu J; Turki H; Rajeswari S; Deng H; Tetzlaff K; Thoma C; Bachelez H
BMJ Open; 2021 Mar; 11(3):e043666. PubMed ID: 33785490
[TBL] [Abstract][Full Text] [Related]
18. Generalized pustular psoriasis: current management status and unmet medical needs in Japan.
Komine M; Morita A
Expert Rev Clin Immunol; 2021 Sep; 17(9):1015-1027. PubMed ID: 34402355
[TBL] [Abstract][Full Text] [Related]
19. Spesolimab for the Treatment of Generalized Pustular Psoriasis.
Bernardo D; Thaçi D; Torres T
Drugs; 2024 Jan; 84(1):45-58. PubMed ID: 38114719
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of spesolimab in Asian patients with a generalized pustular psoriasis flare: Results from the randomized, double-blind, placebo-controlled Effisayil™ 1 study.
Morita A; Tsai TF; Yee EYW; Okubo Y; Imafuku S; Zheng M; Li L; Quaresma M; Thoma C; Choon SE
J Dermatol; 2023 Feb; 50(2):183-194. PubMed ID: 36282833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
